STAT Nov 03
Who will get the first psychedelic approved?:
Today's biotech news examines Gilead's HIV prevention shot goes generic, Bright Minds' seizure drug ...
statnews.com/2026/11/03/biotech-news-who-will-get-the-first-psychedelic-approved/
Paid articlePaywallStory Details
| Last Updated | |
| Total Articles | 1 |
Main Topics
serotonin receptor agonist temporarily altering states of consciousness
Similar to This
Previous
STAT Oct 28
Lilly’s triple-G drug beats Ozempic in head-to-head study: Today's biotech news includes two deaths reported in cell therapy autoimmune trial ...
statnews.com/2026/10/28/biotech-news-lillys-triple-g-drug-beats-ozempic-in-head-to-head-study/
Paid articlePaywall STAT Oct 20
Roche continues to look to China for new drugs: Today's biotech news includes AltruBio's ulcerative colitis drug data, Merck to buy Silence ...
statnews.com/2026/10/20/biotech-news-roches-15b-hunt-for-new-drugs-in-china/
Paid articlePaywall STAT Oct 16
Verastem’s KRAS inhibitor shows promise in pancreatic cancer: Today's biotech news includes how China's biotech boom alters U.S. venture capital ...
statnews.com/2026/10/15/biotech-news-verastem-kras-inhibitor-shows-promise-in-pancreatic-cancer/
Paid articlePaywall STAT Oct 06
Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more
statnews.com/pharmalot/2026/10/06/us-funded-psychedelic-trials-astrazeneca-research-center/
Paid articlePaywall
Definium's LSD-based anxiety, depression drug scores another trial win: Definium Therapeutics said on Monday its LSD-based treatment reduced symptoms of ...
reuters.com/business/healthcare-pharmaceuticals/definiums-lsd-based-drug-lowers-anxiety-second-successful-late-stage-study-2026-09-14/
STAT Sep 17
New startup to test psychedelic-like drug against Parkinson’s symptom: Today's biotech news includes Ariadne Bio testing a psychedelic-like drug for apathy ...
statnews.com/2026/09/17/biotech-news-ariadne-testing-psychedelic-like-drug-parkinsons-apathy/
Paid articlePaywall STAT Aug 04
Three biotechs with three news updates: Today's biotech news includes Gilead wins case over its HIV medicine, Eli Lilly to expand retatrutide access ...
statnews.com/2026/08/04/biotech-news-gilead-wins-case-that-scrutinized-pace-of-drug-development/
Paid articlePaywall
With FDA approval, Celcuity sees big future for its new breast cancer drug: Despite stock dips, the Minnesota biotech firm thinks its innovative therapy and ...
startribune.com/celcuity-fda-approval-revtorpyk-gedatolisib-breast-cancer/601870211
Eli Lilly is buying a psychedelic drugmaker in a $2.8 billion deal: The deal gives Lilly access to a DMT-based nasal spray for treatment-resistant depression ...
qz.com/eli-lilly-ataibeckley-acquisition-psychedelic-depression-071626
STAT Jul 16
FDA approves Merck’s oral PCSK9 drug, a first: Today's biotech news covers Kalshi allowing bets on clinical trial outcomes, Eli Lilly buys a psychedelic ...
statnews.com/2026/07/16/biotech-news-fda-approves-merck-oral-pcsk9-drug-in-a-first/
Paid articlePaywall STAT Jul 14
Akero team, backed by Fairmount, launches new immunology company: Today's biotech news includes the FDA approving an injectable Leqembi ...
statnews.com/2026/07/14/biotech-news-akero-team-launches-new-immunology-company-with-chinese-drug/
Paid articlePaywall
LSD Just Passed Its Biggest Test Yet for Treating Depression: People taking Definium Therapeutics' DT120 showed long-lasting reductions in their depression ...
gizmodo.com/lsd-just-passed-its-biggest-test-yet-for-treating-depression-2000775462
Will Psychedelic Stocks Have A Trippy Ride Under RFK Jr.?: Psychedelic drugs have a long and controversial history. Now, they could be nearing the first FDA ...
investors.com/news/technology/psychedelic-drugs-rfk-jr-depression-ptsd-anxiety-veterans/
STAT Mar 31
Psychedelic biotechs face scrutiny over YouTube promos: Today's biotech news covers Biogen and Eli Lilly making takeover moves, Doctors Without Borders ...
statnews.com/2026/03/31/biotech-news-psychedelic-startups-face-scrutiny-over-youtube-promo/
Paid articlePaywall STAT Mar 31
Over-the-top psychedelic promos could undermine the field’s drug development efforts
statnews.com/2026/03/31/psychedelic-biotech-promotion-scrutinized-helus-atai-influencer-marketing/
Paid articlePaywall
A psychedelic medicine performs well against depression: Regulators are now mulling the results of the late-stage trial
economist.com/science-and-technology/2026/02/19/a-psychedelic-medicine-performs-well-against-depression
Paid articlePaywall A psychedelic medicine performs well against depression: Regulators are now mulling the results of the late-stage trial
economist.com/science-and-technology/2026/02/19/a-psychedelic-medicine-performs-well-against-depression
Paid articlePaywall A psychedelic medicine performs well against depression: Regulators are now mulling the results of the late-stage trial
economist.com/science-and-technology/2026/02/19/a-psychedelic-medicine-performs-well-against-depression
Paid articlePaywall A psychedelic medicine performs well against depression: Regulators are now mulling the results of the late-stage trial
economist.com/science-and-technology/2026/02/19/a-psychedelic-medicine-performs-well-against-depression
Paid articlePaywall STAT Feb 20
Hims’ Super Bowl fallout, and the FDA reverses course: Was Hims' Super Bowl ad the final straw for regulators? STAT's Katie Palmer joins the podcast ...
statnews.com/2026/02/19/hims-super-bowl-ad-moderna-fda-readout-loud/
Next